- Student Records
Programme & Unit Catalogues

PA50337: Managing long term conditions 2

Follow this link for further information on academic years Academic Year: 2015/6
Further information on owning departmentsOwning Department/School: Department of Pharmacy & Pharmacology
Further information on credits Credits: 6
Further information on unit levels Level: Masters UG & PG (FHEQ level 7)
Further information on teaching periods Period: Modular (no specific semester)
Further information on unit assessment Assessment Summary: CW100
Further information on unit assessment Assessment Detail:
  • Assessment detail to be confirmed ( %)
Further information on supplementary assessment Supplementary Assessment: Like-for-like reassessment (where allowed by programme regulations)
Further information on requisites Requisites:
Further information on descriptions Description: Aims:
To update underpinning knowledge of key long term conditions and therapeutics enabling pharmacists to support patients in the self-management of their conditions through optimising medicines use.

Learning Outcomes:
On successful completion of this unit students will be able to:
1. Critically evaluate the evidence base for the management of key long term conditions (LTCs), specifically ischaemic heart disease (IHD), acute coronary syndrome (ACS), myocardial infarction (STEMI and NSTEMI), secondary prevention of IHD, chronic heart failure, lipid modification in primary and secondary cardiovascular disease (CVD risk reduction), peripheral arterial disease (PAD) and depression associated with LTCs. (Intellectual skill) (Medicines Optimisation Tool [MOT], portfolio task)
2. Reflect on your role in reviewing medication and monitoring their safety and effectiveness in patients with the above conditions. (knowledge and understanding)(MOT, Clinical Activity Reflective Exercise [CARE], portfolio tasks)
3. Explain the pathophysiology, symptoms and patient monitoring factors in the above conditions. (MOT, portfolio tasks)
4. Apply good communication and patient centred consultation skills to enhance the patient experience. (Case Based Discussion [CBD])
5. Apply relevant clinical tools and interpret investigations to analyse risk and monitor patients with the above conditions. (taught / facilitated)
6. Safely review medication and optimise medicines use in patients with the above conditions. (MOT)


* Planning & organisation
* Basic clinical examination skills
* Consultation skills
* Study skills
* Handling information
* communication skills
* Working with others
* Problem solving
* Scientific and practical skills
* Improving learning and performance
* Reflective practice
* Information & communication technology.

Ischaemic Heart Disease (IHD) - Angina
Myocardial infarction - STEMI & NSTEMI
Secondary prevention of IHD
Chronic heart failure
Lipid modification in primary & secondary cardiovascular disease
Peripheral arterial disease
Depression associated with LTCs.
Further information on programme availabilityProgramme availability:

PA50337 is Optional on the following programmes:

Department of Pharmacy & Pharmacology
  • TSPA-ADM10 : MSc Clincal Pharmacy Practice (Primary Care)
  • TSPA-ADC12 : PG Cert Clinical Pharmacy Practice (Primary Care)
  • TSPA-ADL11 : PG Dip Clincal Pharmacy Practice (Primary Care)

* This unit catalogue is applicable for the 2015/16 academic year only. Students continuing their studies into 2016/17 and beyond should not assume that this unit will be available in future years in the format displayed here for 2015/16.
* Programmes and units are subject to change at any time, in accordance with normal University procedures.
* Availability of units will be subject to constraints such as staff availability, minimum and maximum group sizes, and timetabling factors as well as a student's ability to meet any pre-requisite rules.